1-2 of 2
Nitya Nathwani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Daratumumab plus RVd for newly diagnosed multiple myeloma: final analysis of the safety run-in cohort of GRIFFIN

Clinical Trials & Observations
Peter M. Voorhees, Cesar Rodriguez, Brandi Reeves, Nitya Nathwani, Luciano J. Costa, Yana Lutska, Padma Bobba, Daniela Hoehn, Huiling Pei, Jon Ukropec, Ming Qi, Thomas S. Lin, Paul G. Richardson
Journal: Blood Advances
Blood Adv (2021) 5 (4): 1092–1096.
https://doi.org/10.1182/bloodadvances.2020003642
Published: 2021
Journal Articles

Identifying CD38 + cells in patients with multiple myeloma: first-in-human imaging using copper-64–labeled daratumumab

Amrita Krishnan, Vikram Adhikarla, Erasmus K. Poku, Joycelynne Palmer, Ammar Chaudhry, Van Eric Biglang-awa, Nicole Bowles, Nitya Nathwani, Michael Rosenzweig, Firoozeh Sahebi, Chatchada Karanes, Jennifer Simpson, James F. Sanchez, Dave Yamauchi, Maria Parayno, Arnab Chowdhury, Enrico Caserta, Guido Marcucci, Russell Rockne, Anna M. Wu, Jeffrey Wong, Stephen J. Forman, David Colcher, Paul Yazaki, John Shively, Flavia Pichiorri
Journal: Blood Advances
Blood Adv (2020) 4 (20): 5194–5202.
https://doi.org/10.1182/bloodadvances.2020002603
Published: 2020
Includes: Supplemental data